S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
NASDAQ:PETQ

PetIQ (PETQ) Stock Price, News & Analysis

$16.28
+0.25 (+1.56%)
(As of 04/19/2024 ET)
Today's Range
$15.95
$16.43
50-Day Range
$15.55
$19.04
52-Week Range
$11.26
$22.98
Volume
162,976 shs
Average Volume
263,374 shs
Market Capitalization
$479.12 million
P/E Ratio
271.38
Dividend Yield
N/A
Price Target
$29.00

PetIQ MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
78.1% Upside
$29.00 Price Target
Short Interest
Healthy
6.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
29.79%
From $0.94 to $1.22 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.29 out of 5 stars

Medical Sector

303rd out of 909 stocks

Drugs, Proprietaries, & Sundries Industry

6th out of 6 stocks

PETQ stock logo

About PetIQ Stock (NASDAQ:PETQ)

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.

PETQ Stock Price History

PETQ Stock News Headlines

White Brook Capital Partners Q1 2024 Commentary
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
PetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call Transcript
Here's what to expect from PetIQ A's earnings
PetIQ: Q4 Earnings Snapshot
PETQ Jul 2024 17.500 put
PETQ Jan 2025 20.000 call
PetIQ Inc. Cl A
PETQ or ABT: Which Is the Better Value Stock Right Now?
Buy Rating for PetIQ Amid Growth Potential in Pet Health Sector
See More Headlines
Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/21/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,933
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.00
High Stock Price Target
$30.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+78.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$2.13 million
Pretax Margin
0.21%

Debt

Sales & Book Value

Annual Sales
$1.10 billion
Cash Flow
$2.68 per share
Book Value
$7.58 per share

Miscellaneous

Free Float
26,694,000
Market Cap
$479.12 million
Optionable
Optionable
Beta
1.64
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

PETQ Stock Analysis - Frequently Asked Questions

Should I buy or sell PetIQ stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings
or view top-rated stocks.

What is PetIQ's stock price target for 2024?

4 analysts have issued twelve-month price targets for PetIQ's stock. Their PETQ share price targets range from $28.00 to $30.00. On average, they predict the company's stock price to reach $29.00 in the next twelve months. This suggests a possible upside of 78.1% from the stock's current price.
View analysts price targets for PETQ
or view top-rated stocks among Wall Street analysts.

How have PETQ shares performed in 2024?

PetIQ's stock was trading at $19.75 at the start of the year. Since then, PETQ stock has decreased by 17.6% and is now trading at $16.28.
View the best growth stocks for 2024 here
.

When is PetIQ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our PETQ earnings forecast
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) posted its earnings results on Wednesday, February, 28th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.38) by $0.22. The business earned $219.93 million during the quarter, compared to analysts' expectations of $189.70 million. PetIQ had a trailing twelve-month return on equity of 11.72% and a net margin of 0.19%.

What ETFs hold PetIQ's stock?

ETFs with the largest weight of PetIQ (NASDAQ:PETQ) stock in their portfolio include ProShares Pet Care ETF (PAWZ).Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).

What guidance has PetIQ issued on next quarter's earnings?

PetIQ issued an update on its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $290.0 million-$310.0 million.

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

PetIQ (PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

Who are PetIQ's major shareholders?

PetIQ's stock is owned by a variety of retail and institutional investors. Top institutional investors include Nepsis Inc. (3.05%), Allspring Global Investments Holdings LLC (0.48%), Los Angeles Capital Management LLC (0.44%) and Banque Cantonale Vaudoise (0.01%). Insiders that own company stock include Allan Hall, John Newland, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Zvi Glasman.
View institutional ownership trends
.

How do I buy shares of PetIQ?

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETQ) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners